PATENT CLAIM ANALYSIS

Application Number: 16035537
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "182000"]

Abstract:
This invention relates to methods of stimulating the activity of the human and animal enteric nervous system. The method comprises orally administering an aminoserol, such as squalamine, a naturally occurring aminosterol isolated from  Squalus acanthias,  or derivatives thereof, to a subject in need.

Claim (Index 27):
The method of  claim 21 , wherein the one or more drugs commonly prescribed to treat Parkinson's disease or related symptoms are selected from the group consisting of levodopa, a dopa decarboxylase inhibitor, a COMT inhibitor, dopamine agonists, MAO-B inhibitors, carbidopa, benserazide, tolcapone, entacapone, bromocriptine, pergolide, pramipexole, ropinirole, piribedil, cabergoline, apomorphine, lisuride, rotigotine, selegiline, rasagiline, amantadine, anticholinergics, clozapine, cholinesterase inhibitors, and modafinil.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 95.0
- Lexical Diversity: 1.19512
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15604489', '15604527', '14329627', '15604452', '12953083']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.863212011475569
- 35 USC 102 Novelty (BERT): 0.553343368945223
- Combined Prediction Score: 0.8322251472225344
- Mean Citation Score: 445.97313
- Max Citation Score: 478.05997
- Similarity Product: 296.65956190750245

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test